{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T14:17:29Z","timestamp":1774966649732,"version":"3.50.1"},"reference-count":77,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2024YFA1107401"],"award-info":[{"award-number":["2024YFA1107401"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Natural Science Foundation of China (NSFC)\n              https:\/\/ror.org\/01h0zpd94","award":["32450812"],"award-info":[{"award-number":["32450812"]}]},{"name":"National Natural Science Foundation of China (NSFC)\n              https:\/\/ror.org\/01h0zpd94","award":["32595480"],"award-info":[{"award-number":["32595480"]}]},{"name":"National Natural Science Foundation of China (NSFC)\n              https:\/\/ror.org\/01h0zpd94","award":["32170803"],"award-info":[{"award-number":["32170803"]}]},{"name":"SMART Investigator Program","award":["40113-13011301225"],"award-info":[{"award-number":["40113-13011301225"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Breast cancer is characterized by profound molecular heterogeneity, which severely limits the clinical utility of universal prognostic tools. To address this gap, we systematically explored transcriptomic profiles in three independent breast cancer cohorts (TCGA, METABRIC, and SCAN-B) via unsupervised clustering. We identified both pan-cancer and PAM50 subtype-specific consensus prognostic gene signatures through log-rank tests and cross-cohort intersection. Single-sample Gene Set Enrichment Analysis (ssGSEA)-derived prognostic scores strongly stratified overall survival across all cohorts, with superior performance over established features (assessed via C-index, time-dependent AUC, NRI, and IDI). Functional enrichment analysis uncovered subtype-specific biological mechanisms: immune-related pathways dominated good-prognostic gene sets in HER2-enriched and Basal-like tumors, while oncogenic pathways characterized poor-prognostic gene sets. Correlation analysis with CIBERSORT-deconvolved immune cell proportions revealed that good-prognostic scores positively correlated with anti-tumor immune cells (CD8+ T cells, M1 macrophages) and negatively with pro-tumor cells (M2 macrophages, Tregs). Independent validation in the Lancet2005 ER+ cohort confirmed that Luminal prognostic gene sets robustly stratified distant relapse-free survival. Collectively, these subtype-specific consensus signatures integrate tumor cell biology and tumor immune microenvironment features, offering robust prognostic tools with potential for future clinical translation.<\/jats:p>","DOI":"10.3390\/ijms27073162","type":"journal-article","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T13:23:17Z","timestamp":1774963397000},"page":"3162","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Subtype-Stratified Consensus Gene Signatures: Bridging Tumor Cell Biology, Immune Microenvironment, and Clinical Prognosis in Breast Cancer"],"prefix":"10.3390","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5115-3248","authenticated-orcid":false,"given":"Xiaoqin","family":"Liu","sequence":"first","affiliation":[{"name":"School of Life Sciences, Zhejiang University, Hangzhou 310058, China"},{"name":"School of Life Sciences, Westlake University, Hangzhou 310024, China"},{"name":"Westlake Laboratory of Life Sciences and Biomedicine, School of Life Sciences, Westlake University, Hangzhou 310024, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0630-7719","authenticated-orcid":false,"given":"Shang","family":"Cai","sequence":"additional","affiliation":[{"name":"School of Life Sciences, Westlake University, Hangzhou 310024, China"},{"name":"Westlake Laboratory of Life Sciences and Biomedicine, School of Life Sciences, Westlake University, Hangzhou 310024, China"},{"name":"Westlake Disease Modeling Lab, Westlake Laboratory of Life Sciences and Biomedicine, Hangzhou 310024, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,3,31]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nature10983","article-title":"The genomic and transcriptomic architecture of 2000 breast tumours reveals novel subgroups","volume":"486","author":"Curtis","year":"2012","journal-title":"Nature"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"The Cancer Genome Atlas Network (2012). Comprehensive molecular portraits of human breast tumours. Nature, 490, 61\u201370.","DOI":"10.1038\/nature11412"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13073-015-0131-9","article-title":"The Sweden Cancerome Analysis Network\u2014Breast (SCAN-B) Initiative: A large-scale multicenter infrastructure towards implementation of breast cancer genomic analyses in the clinical routine","volume":"7","author":"Saal","year":"2015","journal-title":"Genome Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41523-022-00465-3","article-title":"RNA sequencing-based single sample predictors of molecular subtype and risk of recurrence for clinical assessment of early-stage breast cancer","volume":"8","author":"Staaf","year":"2022","journal-title":"npj Breast Cancer"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"10869","DOI":"10.1073\/pnas.191367098","article-title":"Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications","volume":"98","author":"Perou","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/415530a","article-title":"Gene expression profiling predicts clinical outcome of breast cancer","volume":"415","author":"Dai","year":"2002","journal-title":"Nature"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa1804710","article-title":"Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer","volume":"379","author":"Sparano","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"301","DOI":"10.2147\/CMAR.S46483","article-title":"Computational prognostic indicators for breast cancer","volume":"6","author":"Yang","year":"2014","journal-title":"Cancer Manag. Res."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Mei, S., Bai, C., Wang, H., Lin, K., Pan, T., Lu, Y., and Cao, Q. (2025). An Immune Gene Signature Stratifies Breast Cancer Prognosis Through iCAF-Driven Immunosuppressive Microenvironment. Biomedicines, 13.","DOI":"10.3390\/biomedicines13122966"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1056\/NEJMoa021967","article-title":"A gene-expression signature as a predictor of survival in breast cancer","volume":"347","author":"He","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"6012","DOI":"10.1158\/1078-0432.CCR-11-0926","article-title":"A new molecular predictor of distant recurrence in ER-positive, HER2-negative breast cancer adds independent information to conventional clinical risk factors","volume":"17","author":"Filipits","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s00428-012-1204-4","article-title":"Decentral gene expression analysis for ER+\/Her2- breast cancer: Results of a proficiency testing program for the EndoPredict assay","volume":"460","author":"Denkert","year":"2012","journal-title":"Virchows Arch."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1093\/bioinformatics\/bth469","article-title":"Outcome signature genes in breast cancer: Is there a unique set?","volume":"21","author":"Kela","year":"2005","journal-title":"Bioinformatics"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Retecki, K., Seweryn, M., Graczyk-Jarzynka, A., and Bajor, M. (2021). The Immune Landscape of Breast Cancer: Strategies for Overcoming Immunotherapy Resistance. Cancers, 13.","DOI":"10.3390\/cancers13236012"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Moura, T., Laranjeira, P., Caramelo, O., Gil, A.M., and Paiva, A. (2025). Breast Cancer and Tumor Microenvironment: The Crucial Role of Immune Cells. Curr. Oncol., 32.","DOI":"10.3390\/curroncol32030143"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"djw192","DOI":"10.1093\/jnci\/djw192","article-title":"Relevance of Tumor-Infiltrating Immune Cell Composition and Functionality for Disease Outcome in Breast Cancer","volume":"109","author":"Bense","year":"2017","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"11479","DOI":"10.1038\/ncomms11479","article-title":"The somatic mutation profiles of 2,433 breast cancers refines their genomic and transcriptomic landscapes","volume":"7","author":"Pereira","year":"2016","journal-title":"Nat. Commun."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/s41586-019-1007-8","article-title":"Dynamics of breast-cancer relapse reveal late-recurring ER-positive genomic subgroups","volume":"567","author":"Rueda","year":"2019","journal-title":"Nature"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"R76","DOI":"10.1186\/gb-2007-8-5-r76","article-title":"Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors","volume":"8","author":"Herschkowitz","year":"2007","journal-title":"Genome Biol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0092-8674(00)80434-1","article-title":"Cytochrome c and dATP-dependent formation of Apaf-1\/caspase-9 complex initiates an apoptotic protease cascade","volume":"91","author":"Li","year":"1997","journal-title":"Cell"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0092-8674(00)81476-2","article-title":"Reduced apoptosis and cytochrome c-mediated caspase activation in mice lacking caspase 9","volume":"94","author":"Kuida","year":"1998","journal-title":"Cell"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1097-2765(02)00482-3","article-title":"Mechanisms of caspase activation and inhibition during apoptosis","volume":"9","author":"Shi","year":"2002","journal-title":"Mol. Cell"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.str.2010.04.001","article-title":"Structure of an apoptosome-procaspase-9 CARD complex","volume":"18","author":"Yuan","year":"2010","journal-title":"Structure"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0165-3806(01)00190-0","article-title":"Differential localization of the neurofibromatosis 1 (NF1) gene product, neurofibromin, with the F-actin or microtubule cytoskeleton during differentiation of telencephalic neurons","volume":"130","author":"Li","year":"2001","journal-title":"Brain Res. Dev. Brain Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1101\/gad.261677.115","article-title":"Neurofibromatosis-1 regulation of neural stem cell proliferation and multilineage differentiation operates through distinct RAS effector pathways","volume":"29","author":"Chen","year":"2015","journal-title":"Genes. Dev."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"H\u00e4nzelmann, S., Castelo, R., and Guinney, J. (2013). GSVA: Gene set variation analysis for microarray and RNA-seq data. BMC Bioinformatics, 14.","DOI":"10.1186\/1471-2105-14-7"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/nrc2723","article-title":"The first 30 years of p53: Growing ever more complex","volume":"9","author":"Levine","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.cell.2009.04.037","article-title":"Blinded by the Light: The Growing Complexity of p53","volume":"137","author":"Vousden","year":"2009","journal-title":"Cell"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"eabh2443","DOI":"10.1126\/sciadv.abh2443","article-title":"Fatty acid oxidation is a druggable gateway regulating cellular plasticity for driving metastasis in breast cancer","volume":"7","author":"Loo","year":"2021","journal-title":"Sci. Adv."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41580-021-00404-3","article-title":"Cell cycle control in cancer","volume":"23","author":"Matthews","year":"2022","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nrc2602","article-title":"Cell cycle, CDKs and cancer: A changing paradigm","volume":"9","author":"Malumbres","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1056\/NEJMoa2214131","article-title":"Capivasertib in Hormone Receptor-Positive Advanced Breast Cancer","volume":"388","author":"Turner","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1056\/NEJMoa1109653","article-title":"Everolimus in postmenopausal hormone-receptor-positive advanced breast cancer","volume":"366","author":"Baselga","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ctrv.2017.11.002","article-title":"Targeting the Wnt\/beta-catenin pathway in cancer: Update on effectors and inhibitors","volume":"62","author":"Krishnamurthy","year":"2018","journal-title":"Cancer Treat. Rev."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s13072-025-00591-9","article-title":"Acetylation modification of AIM2 by KAT2B suppresses the AKT\/Wnt\/\u03b2-catenin signaling pathway activation and inhibits breast cancer progression","volume":"18","author":"Li","year":"2025","journal-title":"Epigenetics Chromatin"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S0092-8674(00)80702-3","article-title":"A novel transcription factor, T-bet, directs Th1 lineage commitment","volume":"100","author":"Szabo","year":"2000","journal-title":"Cell"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.cell.2006.07.035","article-title":"The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells","volume":"126","author":"Ivanov","year":"2006","journal-title":"Cell"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s10555-007-9049-z","article-title":"Molecular basis of antifolate resistance","volume":"26","author":"Assaraf","year":"2007","journal-title":"Cancer Metastasis Rev."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.2147\/IJN.S150237","article-title":"Development of liposomal pemetrexed for enhanced therapy against multidrug resistance mediated by ABCC5 in breast cancer","volume":"13","author":"Bai","year":"2018","journal-title":"Int. J. Nanomed."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.drup.2006.09.001","article-title":"The role of multidrug resistance efflux transporters in antifolate resistance and folate homeostasis","volume":"9","author":"Assaraf","year":"2006","journal-title":"Drug Resist. Updates"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"e27028","DOI":"10.1016\/j.heliyon.2024.e27028","article-title":"Oleanolic acid inhibits the tumor progression by regulating Lactobacillus through the cytokine-cytokine receptor interaction pathway in 4T1-induced mice breast cancer model","volume":"10","author":"He","year":"2024","journal-title":"Heliyon"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"110930","DOI":"10.1016\/j.ygeno.2024.110930","article-title":"Whole transcriptome sequencing indicated the Anti-tumor immunity of NLRP3 in breast cancer","volume":"116","author":"Qian","year":"2024","journal-title":"Genomics"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Ma, X., Wang, Q., Ren, K., Xu, T., Zhang, Z., Xu, M., Rao, Z., and Zhang, X. (2024). A Review of Antimicrobial Peptides: Structure, Mechanism of Action, and Molecular Optimization Strategies. Fermentation, 10.","DOI":"10.3390\/fermentation10110540"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/s41568-024-00763-x","article-title":"The present and future of the Cancer Dependency Map","volume":"25","author":"Arafeh","year":"2025","journal-title":"Nat. Rev. Cancer"},{"key":"ref_45","unstructured":"DepMap, Broad (2025, July 10). DepMap Public 25Q2. Available online: https:\/\/depmap.org\/portal\/."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/s41586-019-1186-3","article-title":"Next-generation characterization of the Cancer Cell Line Encyclopedia","volume":"569","author":"Ghandi","year":"2019","journal-title":"Nature"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"107742","DOI":"10.1016\/j.celrep.2020.107742","article-title":"Stem Cell Determinant SOX9 Promotes Lineage Plasticity and Progression in Basal-like Breast Cancer","volume":"31","author":"Christin","year":"2020","journal-title":"Cell Rep."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Conde, I., Ribeiro, A.S., and Paredes, J. (2022). Breast Cancer Stem Cell Membrane Biomarkers: Therapy Targeting and Clinical Implications. Cells, 11.","DOI":"10.3390\/cells11060934"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nmeth.3337","article-title":"Robust enumeration of cell subsets from tissue expression profiles","volume":"12","author":"Newman","year":"2015","journal-title":"Nat. Methods"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1200\/CCI.20.00077","article-title":"Characterization of the Tumor Immune Microenvironment Identifies M0 Macrophage-Enriched Cluster as a Poor Prognostic Factor in Hepatocellular Carcinoma","volume":"4","author":"Farha","year":"2020","journal-title":"JCO Clin. Cancer Inform."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/s41598-024-81726-y","article-title":"CXCL8 modulates M0 macrophage proliferation and polarization to influence tumor progression in cervical cancer","volume":"15","author":"Zhao","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.immuni.2023.09.005","article-title":"CD8(+) T cells in the cancer-immunity cycle","volume":"56","author":"Giles","year":"2023","journal-title":"Immunity"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/s41416-020-01048-4","article-title":"Cytotoxic CD8(+) T cells in cancer and cancer immunotherapy","volume":"124","author":"Raskov","year":"2021","journal-title":"Br. J. Cancer"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41698-024-00522-z","article-title":"Targeting M2-like tumor-associated macrophages is a potential therapeutic approach to overcome antitumor drug resistance","volume":"8","author":"Wang","year":"2024","journal-title":"npj Precis. Oncol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1073274820911058","DOI":"10.1177\/1073274820911058","article-title":"Cancer Cells and M2 Macrophages: Cooperative Invasive Ecosystem Engineers","volume":"27","author":"Myers","year":"2020","journal-title":"Cancer Control"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"6096","DOI":"10.1038\/s41598-020-63276-1","article-title":"Role of M1-polarized tumor-associated macrophages in the prognosis of advanced ovarian cancer patients","volume":"10","author":"Gramignano","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"e27151","DOI":"10.1016\/j.heliyon.2024.e27151","article-title":"Synergistic role of activated CD4(+) memory T cells and CXCL13 in augmenting cancer immunotherapy efficacy","volume":"10","author":"Ouyang","year":"2024","journal-title":"Heliyon"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41417-020-0183-x","article-title":"Revisiting the role of CD4(+) T cells in cancer immunotherapy-new insights into old paradigms","volume":"28","author":"Tay","year":"2021","journal-title":"Cancer Gene Ther."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0140-6736(05)17947-1","article-title":"Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer","volume":"365","author":"Wang","year":"2005","journal-title":"Lancet"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"955","DOI":"10.4161\/cbt.10.10.13879","article-title":"Histological, molecular and functional subtypes of breast cancers","volume":"10","author":"Malhotra","year":"2010","journal-title":"Cancer Biol. Ther."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.ccell.2022.05.005","article-title":"Redefining breast cancer subtypes to guide treatment prioritization and maximize response: Predictive biomarkers across 10 cancer therapies","volume":"40","author":"Wolf","year":"2022","journal-title":"Cancer Cell"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.21037\/gs-21-441","article-title":"Advancement of prognostic models in breast cancer: A narrative review","volume":"10","author":"Min","year":"2021","journal-title":"Gland. Surg."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"6650107","DOI":"10.1155\/2021\/6650107","article-title":"Tumor Microenvironment Subtypes and Immune-Related Signatures for the Prognosis of Breast Cancer","volume":"2021","author":"Han","year":"2021","journal-title":"Biomed. Res. Int."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"143","DOI":"10.21037\/atm-21-6748","article-title":"A novel 12-gene prognostic signature in breast cancer based on the tumor microenvironment","volume":"10","author":"Zhu","year":"2022","journal-title":"Ann. Transl. Med."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1093\/annonc\/mdz235","article-title":"Estimating the benefits of therapy for early-stage breast cancer: The St. Gallen International Consensus Guidelines for the primary therapy of early breast cancer 2019","volume":"30","author":"Burstein","year":"2019","journal-title":"Ann. Oncol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"331","DOI":"10.6004\/jnccn.2024.0035","article-title":"Breast Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology","volume":"22","author":"Gradishar","year":"2024","journal-title":"J. Natl. Compr. Canc Netw."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/j.annonc.2021.09.019","article-title":"ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer","volume":"32","author":"Gennari","year":"2021","journal-title":"Ann. Oncol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1093\/nar\/gkv1507","article-title":"TCGAbiolinks: An R\/Bioconductor package for integrative analysis of TCGA data","volume":"44","author":"Colaprico","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.12688\/f1000research.8923.1","article-title":"TCGA Workflow: Analyze cancer genomics and epigenomics data using Bioconductor packages","volume":"5","author":"Silva","year":"2016","journal-title":"F1000Research"},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Mounir, M., Lucchetta, M., Silva, T.C., Olsen, C., Bontempi, G., Chen, X., Noushmehr, H., Colaprico, A., and Papaleo, E. (2019). New functionalities in the TCGAbiolinks package for the study and integration of cancer data from GDC and GTEx. PLoS Comput. Biol., 15.","DOI":"10.1371\/journal.pcbi.1006701"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1200\/CCI.19.00119","article-title":"Multiomic integration of public oncology databases in Bioconductor","volume":"4","author":"Ramos","year":"2020","journal-title":"JCO Clin. Cancer Inform."},{"key":"ref_72","unstructured":"Kassambara, A., Kosinski, M., and Biecek, P. (2025, October 12). Survminer: Drawing Survival Curves Using \u2018ggplot2\u2019. Available online: https:\/\/CRAN.R-project.org\/package=survminer."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.1093\/bioinformatics\/btr511","article-title":"survcomp: An R\/Bioconductor package for performance assessment and comparison of survival models","volume":"27","author":"Culhane","year":"2011","journal-title":"Bioinformatics"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1093\/bioinformatics\/btn374","article-title":"A comparative study of survival models for breast cancer prognostication based on microarray data: Does a single gene beat them all?","volume":"24","author":"Desmedt","year":"2008","journal-title":"Bioinformatics"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"5381","DOI":"10.1002\/sim.5958","article-title":"Estimating and comparing time-dependent areas under receiver operating characteristic curves for censored event times with competing risks","volume":"32","author":"Blanche","year":"2013","journal-title":"Stat. Med."},{"key":"ref_76","first-page":"100141","article-title":"clusterProfiler 4.0: A universal enrichment tool for interpreting omics data","volume":"2","author":"Wu","year":"2021","journal-title":"Innovation"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: An R package for comparing biological themes among gene clusters","volume":"16","author":"Yu","year":"2012","journal-title":"Omics"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/7\/3162\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T13:26:54Z","timestamp":1774963614000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/7\/3162"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,31]]},"references-count":77,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["ijms27073162"],"URL":"https:\/\/doi.org\/10.3390\/ijms27073162","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,31]]}}}